Home / Spain / Laboratorios Farmaceuticos Rovi, S.A.
Laboratorios Farmaceuticos Rovi, S.A.
Short position disclosed on July 24, 2026.
Evolution of the disclosed total
February 22, 2011 today
Open positions
| Fund | Twelve months | % of capital | Over the year | Since |
|---|---|---|---|---|
| JPMorgan Asset Management (UK) Limited | 1.51% | +0.71 pt | July 24, 2026 |
In the United States LABFF (OTC): 12,218 shares sold short on August 31, 2026. FINRA names no fund.
On the other side: the funds that hold Laboratorios Farmaceuticos Rovi, S.A. Titelia
Get the moves on Laboratorios Farmaceuticos Rovi, S.A. by mail.
No account: one address, one link to confirm, one link to stop in every message.
History of disclosures
Download 19 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats
Other companies sold short in Spain
- Edreams Odigeo, S.A. 5.97% of the capital sold short
- Solaria Energia y Medioambiente, S.A. 5.94% of the capital sold short
- Enagas, S.A. 4.78% of the capital sold short
- Tecnicas Reunidas, S.A. 3.61% of the capital sold short
- Amper, S.A. 3.20% of the capital sold short
- Viscofan, S.A. 2.44% of the capital sold short
- Grifols, S.A. 1.81% of the capital sold short
- Indra Sistemas, S.A. 1.78% of the capital sold short
- Tubacex, S.A. 1.49% of the capital sold short
- Ence Energia y Celulosa, S.A. 1.48% of the capital sold short
- Cellnex Telecom, S.A. 1.40% of the capital sold short
- Repsol, S.A. 1.24% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, Laboratorios Farmaceuticos Rovi, S.A., source CNMV, data as at July 24, 2026, https://www.quivad.com/action/laboratorios-farmaceuticos-rovi-s-a